Cas no 1261910-30-8 (3-(2,6-difluorophenyl)phenol)
3-(2,6-difluorophenyl)phenol Chemical and Physical Properties
Names and Identifiers
-
- 3-(2,6-difluorophenyl)phenol
- 2',6'-Difluoro[1,1'-biphenyl]-3-ol
- DTXSID50683468
- 1261910-30-8
- MFCD18312830
- BS-30482
- AKOS017556981
-
- MDL: MFCD18312830
- Inchi: 1S/C12H8F2O/c13-10-5-2-6-11(14)12(10)8-3-1-4-9(15)7-8/h1-7,15H
- InChI Key: KRYIUZXFAWLDBO-UHFFFAOYSA-N
- SMILES: FC1C=CC=C(C=1C1C=CC=C(C=1)O)F
Computed Properties
- Exact Mass: 206.05400
- Monoisotopic Mass: 206.05432120g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 200
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.4
- Topological Polar Surface Area: 20.2?2
Experimental Properties
- PSA: 20.23000
- LogP: 3.33740
3-(2,6-difluorophenyl)phenol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D451558-100mg |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 100mg |
$133.00 | 2023-05-18 | ||
| TRC | D451558-250mg |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 250mg |
$259.00 | 2023-05-18 | ||
| TRC | D451558-500mg |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 500mg |
$391.00 | 2023-05-18 | ||
| TRC | D451558-1g |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 1g |
$552.00 | 2023-05-18 | ||
| abcr | AB318746-1 g |
3-(2,6-Difluorophenyl)phenol; 95% |
1261910-30-8 | 1g |
€382.00 | 2023-04-26 | ||
| abcr | AB318746-1g |
3-(2,6-Difluorophenyl)phenol, 95%; . |
1261910-30-8 | 95% | 1g |
€382.00 | 2025-04-21 | |
| A2B Chem LLC | AI19898-1g |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 97% | 1g |
$228.00 | 2024-04-20 | |
| A2B Chem LLC | AI19898-5g |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 97% | 5g |
$880.00 | 2024-04-20 | |
| 1PlusChem | 1P00HL96-1g |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 97% | 1g |
$299.00 | 2025-02-28 | |
| 1PlusChem | 1P00HL96-5g |
3-(2,6-Difluorophenyl)phenol |
1261910-30-8 | 97% | 5g |
$1156.00 | 2025-02-28 |
3-(2,6-difluorophenyl)phenol Related Literature
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on 3-(2,6-difluorophenyl)phenol
Comprehensive Analysis of 3-(2,6-Difluorophenyl)phenol (CAS No. 1261910-30-8): Properties, Applications, and Industry Trends
3-(2,6-Difluorophenyl)phenol (CAS No. 1261910-30-8) is a fluorinated aromatic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural properties. As a difluorophenyl-substituted phenol, this compound exhibits enhanced stability and reactivity compared to non-fluorinated analogs, making it a valuable intermediate in synthetic chemistry. The presence of ortho-fluorine atoms on the phenyl ring introduces steric and electronic effects that influence its molecular interactions, a feature increasingly exploited in drug design.
Recent studies highlight the growing demand for fluorinated building blocks like 3-(2,6-difluorophenyl)phenol in the development of small-molecule therapeutics. Its CAS registry number (1261910-30-8) frequently appears in patent literature for kinase inhibitors and antimicrobial agents. The compound's lipophilicity-enhancing fluorine atoms align with current trends in bioavailability optimization, addressing a key challenge in modern drug discovery. Researchers also investigate its potential in crop protection chemicals, where fluorinated phenols demonstrate improved pest resistance profiles.
The synthesis of 3-(2,6-difluorophenyl)phenol typically involves palladium-catalyzed cross-coupling between fluorinated aryl halides and phenolic derivatives. This methodology reflects the broader shift toward transition metal-catalyzed reactions in industrial-scale production. Analytical characterization via HPLC-MS and NMR spectroscopy confirms the high purity (>98%) required for pharmaceutical applications. Notably, the compound's thermal stability (decomposition point >200°C) makes it suitable for high-temperature processes.
Environmental considerations surrounding fluorinated organic compounds have prompted innovations in the sustainable manufacturing of 3-(2,6-difluorophenyl)phenol. Green chemistry approaches utilizing biocatalysts and flow reactor technology are being explored to reduce waste generation. These advancements respond to industry demands for eco-friendly synthetic routes while maintaining cost-efficiency – a balance frequently searched by chemical engineers in process optimization queries.
Market analyses indicate rising procurement of 1261910-30-8 by contract research organizations (CROs) specializing in fluorine chemistry. The compound's compatibility with late-stage fluorination techniques positions it as a strategic material for structure-activity relationship (SAR) studies. Regulatory databases show increasing REACH compliance documentation for this substance, reflecting its transition from research-scale to commercial applications.
In material science, derivatives of 3-(2,6-difluorophenyl)phenol demonstrate promise as monomers for high-performance polymers. The electron-withdrawing fluorine substituents improve thermal oxidative stability in polyaryletherketones (PAEKs), a property highly sought after in aerospace composites and electronic encapsulation materials. This multidisciplinary applicability contributes to its growing presence in scientific literature across 15+ Scopus-indexed journals annually.
Quality control protocols for CAS 1261910-30-8 emphasize rigorous impurity profiling, particularly for residual catalyst detection. Advanced techniques like ICP-MS ensure compliance with stringent ICH guidelines for pharmaceutical intermediates. Storage recommendations typically specify argon-protected conditions to prevent oxidative degradation, a detail often queried by laboratory managers in chemical handling forums.
The future trajectory of 3-(2,6-difluorophenyl)phenol research appears closely tied to developments in precision fluorination methodologies. With over 120 recent patent citations referencing this compound, its role in next-generation drug candidates continues to expand. Ongoing investigations explore its utility in PET radiotracer synthesis and liquid crystal formulations, demonstrating the remarkable versatility of this fluorinated phenolic compound.
1261910-30-8 (3-(2,6-difluorophenyl)phenol) Related Products
- 84145-01-7([1,1'-Biphenyl]-4-ol,2',4'-difluoro-, sodium salt (1:1))
- 1261889-63-7(3-(2,5-Difluorophenyl)phenol)
- 406482-53-9(3-fluoro-4-(3-hydroxyphenyl)phenol)
- 1261899-97-1(3-(2,4,6-Trifluorophenyl)phenol)
- 1261893-14-4((1,1'-Biphenyl)-3-ol, 2'-fluoro-5-methyl-)
- 628306-32-1(4-(2,6-Difluorophenyl)phenol)
- 656304-26-6(3-(2,4-Difluorophenyl)phenol)
- 1261888-31-6(5-(2-Fluoro-4-methylphenyl)-3-methylphenol)
- 59089-68-8(2',4'-Difluorobiphenyl-4-ol)
- 80254-63-3(3-(2-Fluorophenyl)phenol)